David E. Lazar, 10% Owner at Cyclacel Pharmaceuticals, Inc. (CYCC), sold 6,750 shares at $12.36 ($83K) on 2025-07-30, disclosed to the SEC on 2025-08-04.
Open-market sale of $83k CYCC by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| TTNP | BUY | 2022-07-08 | $3.8M | — | Filing → |